M. Dokmanovic

发表

VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation

N. Mohan, Yi Shen, M. Dokmanovic, 2016, Oncotarget.

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.

G. Perez, L. Ngo, P. Marks, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1.

N. Mohan, Yi Shen, M. Dokmanovic, 2014, Cellular signalling.

Histone Deacetylase Inhibitors: Overview and Perspectives

P. Marks, M. Dokmanovic, Milos Dokmanovic, 2007, Molecular Cancer Research.

Histone deacetylase inhibitors selectively suppress expression of HDAC7

G. Perez, L. Ngo, P. Marks, 2007, Molecular Cancer Therapeutics.

Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice

N. Mohan, Yi Shen, M. Dokmanovic, 2013, PloS one.

Mechanisms contributing to ado-trastuzumab emtansine-induced toxicities: a gateway to better understanding of ADC-associated toxicities.

N. Mohan, M. Dokmanovic, Yukinori Endo, 2021, Antibody therapeutics.

Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab

N. Mohan, M. Dokmanovic, Yukinori Endo, 2017, Expert opinion on drug metabolism & toxicology.

Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition

Yun Wu, Yi Shen, M. Dokmanovic, 2014, Cancer biology & therapy.

Induction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids

I. Roninson, M. Dokmanovic, Milos Dokmanovic, 2003, Journal of cellular biochemistry.

Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.

I. Roninson, M. Dokmanovic, W. Stein, 2006, Cancer research.

Retinoid-Induced Growth Arrest of Breast Carcinoma Cells Involves Co-Activation of Multiple Growth-Inhibitory Genes

I. Roninson, Jing Fang, M. Dokmanovic, 2002, Cancer biology & therapy.

Mechanisms contributing to ado-trastuzumab emtansine ( TDM 1 )-induced toxicities : a gateway to better understanding ADC-associated toxicities

N. Mohan, M. Dokmanovic, Yukinori Endo, 2021 .

Mechanisms of Trastuzumab Resistance and Opportunities to Overcome Therapeutic Resistance

M. Dokmanovic, W. J. Wu, W. J. Wu, 2013 .

Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1

N. Mohan, Yi Shen, M. Dokmanovic, 2022, Pharmaceutics.

Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

G. Perez, L. Ngo, P. Marks, 2006, Proceedings of the National Academy of Sciences.

A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

E. Kandel, I. Roninson, K. Christov, 1999, Cancer research.

Prospects: Histone deacetylase inhibitors

M. Dokmanovic, Paul A Marks, Milos Dokmanovic, 2005, Journal of cellular biochemistry.

pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation.

Yi Shen, M. Dokmanovic, D. Hirsch, 2010, Cancer research.

Monitoring Trastuzumab Resistance and Cardiotoxicity: A Tale of Personalized Medicine.

M. Dokmanovic, W. J. Wu, W. J. Wu, 2015, Advances in clinical chemistry.

Trastuzumab-Resistance and Breast Cancer

M. Dokmanovic, W. J. Wu, W. J. Wu, 2011 .

Trastuzumab Regulates IGFBP-2 and IGFBP-3 to Mediate Growth Inhibition: Implications for the Development of Predictive Biomarkers for Trastuzumab Resistance

Yi Shen, M. Dokmanovic, D. Hirsch, 2011, Molecular Cancer Therapeutics.

Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer

Yi Shen, M. Dokmanovic, D. Hirsch, 2009, Molecular Cancer Therapeutics.

Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications.

D. Sterner, S. Berger, K. Ingvarsdóttir, 2006, Genes & development.

Histone deacetylase inhibitors: discovery and development as anticancer agents

P. Marks, M. Dokmanovic, Milos Dokmanovic, 2005, Expert opinion on investigational drugs.

Ado-Trastuzumab Emtansine Targets Hepatocytes Via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity

N. Mohan, Yi Shen, M. Dokmanovic, 2015, Molecular Cancer Therapeutics.

Trastuzumab-induced HER 2 phosphorylation : exploring the mechanisms and implications

M. Dokmanovic, W. J. Wu, W. J. Wu, 2015 .

Trastuzumab-induced HER2 phosphorylation: exploring the mechanisms and implications

M. Dokmanovic, W. J. Wu, W. J. Wu, 2014 .

Correction: Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice

N. Mohan, Yi Shen, M. Dokmanovic, 2014, PLoS ONE.

Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers.

N. Mohan, M. Dokmanovic, Jiangsong Jiang, 2018, Antibody therapeutics.

Small GTPase Rho regulates R-cadherin through Dia1/profilin-1.

Yi Shen, M. Dokmanovic, D. Hirsch, 2012, Cellular signalling.

Legal History Course Development Challenges in Croatia, Serbia and Macedonia

M. Dokmanovic, 2013 .